Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Inventory Average for 13 consecutive years, with $144.8 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 1.66% to $144.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $144.8 million through Dec 2025, up 1.66% year-over-year, with the annual reading at $139.9 million for FY2025, 12.85% up from the prior year.
  • Inventory Average hit $144.8 million in Q4 2025 for Ani Pharmaceuticals, up from $142.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $144.8 million in Q4 2025 to a low of $60.4 million in Q1 2021.
  • Historically, Inventory Average has averaged $108.0 million across 5 years, with a median of $105.4 million in 2022.
  • Biggest five-year swings in Inventory Average: soared 52.92% in 2022 and later grew 1.66% in 2025.
  • Year by year, Inventory Average stood at $78.2 million in 2021, then surged by 34.75% to $105.3 million in 2022, then grew by 3.37% to $108.9 million in 2023, then surged by 30.78% to $142.4 million in 2024, then grew by 1.66% to $144.8 million in 2025.
  • Business Quant data shows Inventory Average for ANIP at $144.8 million in Q4 2025, $142.4 million in Q3 2025, and $137.9 million in Q2 2025.